Holen Sie sich die Stockscreener-App
6.00
6.01%
0.34
Handel nachbörslich:
6.00
Schlusskurs vom Vortag:
$5.66
Offen:
$6.18
24-Stunden-Volumen:
85,417
Relative Volume:
2.26
Marktkapitalisierung:
$1.16B
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-0.50%
1M Leistung:
-44.19%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$5.53
$6.18
1-Wochen-Bereich:
$5.50
$6.77
52-Wochen-Spanne:
$4.99
$14.29
Ss Innovations International Inc Stock (SSII) Company Profile
Firmenname
Ss Innovations International Inc
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie SSII mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SSII
Ss Innovations International Inc
|
6.00 | 1.17B | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
133.94 | 231.14B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.83 | 154.60B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
383.10 | 146.12B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
87.00 | 105.64B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.77 | 45.60B | 5.54B | 4.18B | 623.10M | 7.00 |
Ss Innovations International Inc Aktie (SSII) Neueste Nachrichten
Proud Moment for India: SS Innovations Rings Nasdaq Opening Bell, Showcases Indian Medtech Excellence on Global Stage - udaipurkiran.com
Indian medtech start-up SS Innovations makes Nasdaq debut, showcasing global leadership in robotic surgery - eHealth Magazine
Indian medtech startup SSII celebrates debut on Nasdaq - News9live
SS Innovations International rings Nasdaq opening bell, putting Indian medtech on the global map - Healthcare Radius
SS Innovations Unveils New Strategic Expansion Plans - TipRanks
SS Innovations International Inc Rings the Opening Bell - Nasdaq
SS Innovations Rings Nasdaq Bell After Uplisting - TipRanks
SS Innovations International, Inc. to Ring Nasdaq Opening Bell Celebrating Uplisting and Milestone Surgeries - Nasdaq
SS Innovations to Ring the Nasdaq Opening Bell on Tuesday, June 3, 2025 - GlobeNewswire
Medical Robotics Breakthrough: SS Innovations Hits 4,000 Surgery Milestone as it Joins Nasdaq - Stock Titan
SS Innovations reaches 4,000 robotic surgeries with SSi Mantra robotic system - The Robot Report
SS Innovations International Becomes Oversold (SSII) - Nasdaq
SSII Unchanged on Developments in Robotics - Baystreet.ca
SS Innovations Hits 4,000 Surgeries Milestone - TipRanks
SS Innovations Surpasses Milestone of 4,000 Robotic - GlobeNewswire
Surgical Robot Achieves Perfect Safety Record Across 4,000 Operations Including Remote Heart Surgeries - Stock Titan
SS Innovations appoints new CEO for Asia Pacific By Investing.com - Investing.com Nigeria
SS Innovations appoints new CEO for Asia Pacific - Investing.com Australia
SS Innovations revenue jumps 40.8% to USD 5.1M in Q1 2025 - Medical Buyer
SS Innovations Reports Record Q1 Revenue Growth - TipRanks
SS Innovations International, Inc. Reports Record Quarterly Revenue of $5.1 Million, Driven by Increased SSi Mantra 3 Sales and Plans for FDA De Novo Application - Nasdaq
Earnings Flash (SSII) SS Innovations International Posts Q1 Revenue $5.1M - marketscreener.com
SS Innovations Reports First Quarter 2025 Financial Results - The Manila Times
SS Innovations to submit de novo classification request for surgical robotic system - Yahoo Finance
SS Innovations to seek FDA approval for robotic system By Investing.com - Investing.com Nigeria
SS Innovations reiterates guidance for Q1 2025 - MSN
SS Innovations to Submit De Novo Application to the FDA for - GlobeNewswire
SS Innovations Plans FDA Submission for Robotic System - TipRanks
SS Innovations to seek FDA approval for robotic system - Investing.com
SS Innovations to Submit De Novo Application to the FDA for the SSi Mantra 3 Surgical Robotic ... - Bluefield Daily Telegraph
SS Innovations to Submit De Novo Application to the FDA for the SSi Mantra 3 Surgical Robotic System for Multiple Indications - Stock Titan
SS Innovations Reports Surge in April 2025 Orders - TipRanks
SS Innovations Reiterates Guidance for First Quarter 2025 and Provides Commentary on Second Quarter 2025 Order Trends - The Manila Times
SS Innovations Reiterates Guidance for First Quarter 2025 and Provides Commentary on Second ... - Bluefield Daily Telegraph
SS Innovations Reiterates Guidance for First Quarter 2025 - GlobeNewswire
Surgical Robot Orders Surge 200%: SS Innovations Reveals Strong Q1 Performance and Record-Breaking April Sales - Stock Titan
SS Innovations Announces Completion of BDO Audit Process and Issues Update on Plans for NASDAQ Uplisting - The Globe and Mail
SS Innovations names interim CFO amid leadership change By Investing.com - Investing.com Nigeria
SS Innovations Announces CFO Transition - marketscreener.com
SS Innovations Appoints Arvind Palaniappan as Interim CFO - TipRanks
SS Innovations names interim CFO amid leadership change - Investing.com
SS Innovations Announces Chief Financial Officer Transition - GlobeNewswire
Surgical Robotics Leader SS Innovations Appoints New CFO After Major Nasdaq Milestone - Stock Titan
SS Innovations International, Inc., Makers Of SSI Mantra, Makes Historic NASDAQ Debut - BW Healthcare World
SS Innovations International, Inc., Makers of SSI Mantra, Makes Historic NASDAQ Debut - areporterlive.com
Indian medical tech global - Udaipur Kiran
SS Innovations NASDAQ debut - udaipurkiran.com
SSII Stock Price and Chart — NASDAQ:SSII - TradingView
SS Innovations International listed on US exchange Nasdaq - The Economic Times
SS Innovations to Uplist to Nasdaq - Stock Titan
SS Innovations International, Inc. SEC 10-K Report - TradingView
Finanzdaten der Ss Innovations International Inc-Aktie (SSII)
Es liegen keine Finanzdaten für Ss Innovations International Inc (SSII) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.61%
Kapitalisierung:
|
Volumen (24h):